Compare Nomura Holdings Inc (NMR) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nomura Holdings Inc vs UnitedHealth Group Inc — how do they compare? Nomura Holdings Inc trades at $9.8 (market cap $28.69B), while UnitedHealth Group Inc trades at $402.64 (market cap $371.19B). The key difference: UnitedHealth Group Inc is far larger — about 12.9× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays the higher dividend (3.3%). Which is the better fit depends on your goals.
| NMR | UNH | |
|---|---|---|
Market Cap | $28.69B | $371.19B |
Sector | Financials | Health |
52-Week High | $10.04 | $436.35 |
52-Week Low | $6.73 | $259.02 |
Dividend Yield | 3.3% | 2.27% |
Enterprise Value | — | $417.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nomura Holdings (NMR) trades at $9.95, up 0.3% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamentals, including a P/E of 11.77 and net income margin of 20.4%, supported by record annual profit in 2025. Recent Q2 2026 earnings beat expectations, and revenue growth trends upward, though cash flow from operations remains negative.
Outlook is positive with valuation appeal and earnings momentum, but risks include volatile cash flows, high debt levels, and reliance on wholesale revenue. Analysts are mixed, with 33% buy ratings. The stock presents a value opportunity amid bullish technicals, yet investors should weigh debt concerns against growth prospects.
UnitedHealth Group (UNH) trades at $402.19, down 1.2% in the last session, with a bearish technical signal but strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has consistently beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
Outlook remains positive due to aging demographics and Medicare growth, though regulatory risks and margin pressure present challenges. With 82.7% of analysts rating it a Buy and a consensus price target of $476.50, the stock offers upside potential, balanced by litigation and competitive threats in the managed care sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
